Mark Fish

2.5k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

Mark Fish is a scholar working on Psychiatry and Mental health, Epidemiology and Neurology. According to data from OpenAlex, Mark Fish has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in Mark Fish's work include Dementia and Cognitive Impairment Research (11 papers), Chronic Disease Management Strategies (4 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Mark Fish is often cited by papers focused on Dementia and Cognitive Impairment Research (11 papers), Chronic Disease Management Strategies (4 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Mark Fish collaborates with scholars based in United Kingdom, New Zealand and Switzerland. Mark Fish's co-authors include Antony Bayer, John Gallacher, Yoav Ben‐Shlomo, Janet Pickering, Andrea Malaspina, Linda Greensmith, Shah Ebrahim, Richard W. Orrell, Neil Pearce and Jens Kühle and has published in prestigious journals such as Neurology, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Mark Fish

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurofilament light chain

2015 390 citations Ching‐Hua Lu, Corrie Macdonald‐Wallis et al. Neurology profile →

Peers

Countries citing papers authored by Mark Fish

Since Specialization

Citations

This map shows the geographic impact of Mark Fish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fish more than expected).

Fields of papers citing papers by Mark Fish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Fish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fish. The network helps show where Mark Fish may publish in the future.

Co-authorship network of co-authors of Mark Fish

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Fish. A scholar is included among the top collaborators of Mark Fish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Fish. Mark Fish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Informant accuracy of IQCODE, AD8 and GPCOGi for diagnosis of dementia: does your friend know best? 2025 ·BMC Primary Care ·(unknown), Sam Creavin, Mark Fish, Sarah Cullum, Antony Bayer, Sarah Purdy, Yoav Ben‐Shlomo	1
2	Predictors and prognosis of population-based subjective cognitive decline: longitudinal evidence from the Caerphilly Prospective Study (CaPS) 2023 ·BMJ Open ·Harriet A. Ball, Elizabeth Coulthard, Mark Fish, Antony Bayer, John Gallacher, Yoav Ben‐Shlomo	1
3	A Diagnostic Test Accuracy Study Investigating General Practitioner Clinical Impression and Brief Cognitive Assessments for Dementia in Primary Care, Compared to Specialized Assessment 2023 ·Journal of Alzheimer s Disease ·Sam Creavin, Mark Fish, Michael Lawton, Sarah Cullum, Antony Bayer, Sarah Purdy, Yoav Ben‐Shlomo	2
4	Clinical judgment of GPs for the diagnosis of dementia: a diagnostic test accuracy study 2021 ·BJGP Open ·Sam Creavin, Judy Haworth, Mark Fish, Sarah Cullum, Antony Bayer, Sarah Purdy, Yoav Ben‐Shlomo	7
5	Sleep and the risk of cognitive impairment and dementia: further insights from the Caerphilly Prospective Study 2021 ·BJPsych Open ·(unknown), Elizabeth Coulthard, Antony Bayer, Mark Fish, John Gallacher, Yoav Ben‐Shlomo	1
6	Skull base aspergillosis in an immunocompetent elderly man with early response to steroid 2018 ·BMJ Case Reports ·(unknown), Christopher Price, Mark Fish, Luke Bennetto	4
7	Towards improving diagnosis of memory loss in general practice: TIMeLi diagnostic test accuracy study protocol 2016 ·BMC Family Practice ·Sam Creavin, Sarah Cullum, Judy Haworth, Lesley Wye, Antony Bayer, Mark Fish, Sarah Purdy, Yoav Ben‐Shlomo	3
8	Neurofilament light chain breakdown → 2015 ·Neurology ·Ching‐Hua Lu, Corrie Macdonald‐Wallis, Elizabeth Gray, Neil Pearce, Axel Petzold, Niklas Norgren, Gavin Giovannoni, Pietro Fratta, Katie Sidle, Mark Fish, Richard W. Orrell, Robin Howard, Kevin Talbot, Linda Greensmith, Jens Kühle, Martin R. Turner, Andrea Malaspina	390
9	Clinical history for diagnosis of dementia in men: Caerphilly Prospective Study 2015 ·British Journal of General Practice ·Sam Creavin, Mark Fish, John Gallacher, Antony Bayer, Yoav Ben‐Shlomo	5
10	Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study 2014 ·Journal of Neurology Neurosurgery & Psychiatry ·Ching‐Hua Lu, Axel Petzold, (unknown), (unknown), Corrie Macdonald‐Wallis, (unknown), Neil Pearce, Jens Kühle, Gavin Giovannoni, Pietro Fratta, Katie Sidle, Mark Fish, Richard W. Orrell, Robin Howard, Linda Greensmith, Andrea Malaspina	83
11	The Role of IGF-I, IGF-II, and IGFBP-3 in Male Cognitive Aging and Dementia Risk: The Caerphilly Prospective Study 2014 ·Journal of Alzheimer s Disease ·Christopher J. Green, Jeffrey M P Holly, Antony Bayer, Mark Fish, Shah Ebrahim, John Gallacher, Yoav Ben‐Shlomo	23
12	High caloric intake, poor cognition and dementia: the Caerphilly Prospective Study 2012 ·European Journal of Epidemiology ·Sam Creavin, John Gallacher, Janet Pickering, A M Fehily, Mark Fish, Shah Ebrahim, Antony Bayer, Yoav Ben‐Shlomo	4
13	Perry syndrome due to the DCTN1 G71R mutation: A distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure 2010 ·Movement Disorders ·(unknown), Mark Fish, Jonathan D. Rohrer, Elisa Majounie, Nigel Williams, (unknown), Jason D. Warren, Huw R. Morris	30
14	Sleep disturbance and daytime sleepiness predict vascular dementia 2010 ·Journal of Epidemiology & Community Health ·P C Elwood, Antony Bayer, Mark Fish, Janet Pickering, Caroline M. Mitchell, John Gallacher	96
15	Does Anxiety Affect Risk of Dementia? Findings From the Caerphilly Prospective Study 2009 ·Psychosomatic Medicine ·John Gallacher, Antony Bayer, Mark Fish, Janet Pickering, Sofia Pedro, Frank Dunstan, Shah Ebrahim, Yoav Ben‐Shlomo	107
16	Prevalence and Pattern of Cognitive Impairment in a Community Cohort of Men in South Wales: Methodology and Findings from the Caerphilly Prospective Study 2008 ·Neuroepidemiology ·Mark Fish, Antony Bayer, John Gallacher, (unknown), Janet Pickering, (unknown), Frank Dunstan, Yoav Ben‐Shlomo, Shah Ebrahim	31
17	Bacterial meningitis resulting in visual impairment and panhypopituitarism 2007 ·British Journal of Hospital Medicine ·Ceri Lynch, Mark Fish	4
18	Vascular subcortical syndrome of aging 2004 ·Reviews in Clinical Gerontology ·Mark Fish, Antony Bayer	1
19	The Doctor???s Duty to the Elderly Patient in Clinical Trials 2003 ·Drugs & Aging ·Antony Bayer, Mark Fish	7
20	Radiologic-pathologic correlation. Diffuse pontine astrocytoma. 1993 ·PubMed ·(unknown), (unknown), James G. Smirniotopoulos, (unknown), Mark Fish	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact